European life sciences fundraising and investments still haven’t reached anywhere near the heady 2006 levels But news of Index Ventures most recent fundraising are sending vibes of optimism and hope for a revival of European biotech.

Vaultive said it raised $10-million in a round led by .406 Ventures, New Science Ventures and Harmony Partners. The New York developer of cloud-based data encryption says its first product is undergoing beta testing. PRESS RELEASE Cloud Data Encryption Solutions Provider Vaultive Raises $10 Million Security Industry Luminaries Join Forces to Create New Solution Designed [...]

Santa Monica, Calif.-based TigerText Inc., maker of secure mobile messaging technology for healthcare enterprises, has raised $8.2 million in financing, bringing its total raised to $10 million. The Series A investment was co-led by Easton Capital and New Science Ventures. As part of their investment, John Friedman, Managing Partner of Easton Capital; and Somu Subramaniam, Managing Partner of NSV, join the company’s board.

Seattle-based Resolve Therapeutics has closed a $2 million Series A round from New York-based venture firms New Science Ventures and Easton Capital. In connection with the round, the company has added three to its board: Peter Kiener, chief executive of Zyngenia, is now chairman. Somu Subramaniam, founder and managing partner of New Science Ventures, joins [...]

Achronix Semiconductor Corp., a maker of field-programmable gate arrays, has held a first close of a planned $45 million Series C mezzanine financing round. More that $40 million has been committed, and the company expects to close on an additional $5 million within the next two months. The San Jose, Calif.-based company has raised at least $68.4 million in two previous rounds from investors including Argonaut Private Equity, Battery Ventures, New Science Ventures, Easton Capital Investment Group and Entrepia Ventures.

Seahorse Bioscience, Inc., a Billerica, Mass.-based medical instrument company, closed a $5 million round of financing. Investors in the Series D round included Commonwealth Capital Ventures, FLIR Systems Inc, Rock Maple Ventures, Life Sciences Partners, Oxford Bioscience Partners, Healthcare Ventures, New Science Ventures and HLM Venture Partners.